SCHEMBL21361480

SCHEMBL21361480

COc1cc(F)cc(N2CCN(C(C)I)CC2C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.38
CYP1A2 P05177 1/20 0.38
PRKG1 Q13976 1/20 0.38
ADAMTS5 Q9UNA0 11/20 0.37
MMP13 P45452 3/20 0.37
MMP2 P08253 5/20 0.35
MMP14 P50281 5/20 0.35
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CPS1 P31327 2/20 0.34
FFAR4 Q5NUL3 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23102230 0.90 ROCK2 (0.39) ROCK2CYP1A2PRKG1ADAMTS5MMP13
SCHEMBL21361621 0.82 CPS1 (0.36) ROCK2CYP1A2PRKG1ADAMTS5MMP13
SCHEMBL21361434 0.75 ROCK2 (0.35) ROCK2CYP1A2PRKG1ADAMTS5LMNA
SCHEMBL13899013 0.72 KDM4E (0.44) CYP1A2MAPTKDM4ELMNAHTT
SCHEMBL21358949 0.71 ADRB1 (0.49) CYP1A2
SCHEMBL21358947 0.71 ADRB1 (0.49) CYP1A2
SCHEMBL21359189 0.71 ADRB1 (0.49) CYP1A2
SCHEMBL17897270 0.68 ADAMTS5 (0.43) CYP1A2ADAMTS5MMP2MAPTKDM4E
SCHEMBL19003576 0.68 ADAMTS5 (0.43) CYP1A2ADAMTS5MMP2MAPTKDM4E
SCHEMBL17897284 0.68 ADAMTS5 (0.43) CYP1A2ADAMTS5MMP2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019178510-A1 TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2019-09-19 WO disclosed